MC2418A1 - Procédé de préparation d'un acide (-) - (3R)-3-méthyl-4-[4-[4- (4-pyridyl) pipérazine-1-yl] phénoxy]butyrique et d'une composition pharmaceutique le contenant - Google Patents

Procédé de préparation d'un acide (-) - (3R)-3-méthyl-4-[4-[4- (4-pyridyl) pipérazine-1-yl] phénoxy]butyrique et d'une composition pharmaceutique le contenant

Info

Publication number
MC2418A1
MC2418A1 MC2347A MC2347A MC2418A1 MC 2418 A1 MC2418 A1 MC 2418A1 MC 2347 A MC2347 A MC 2347A MC 2347 A MC2347 A MC 2347A MC 2418 A1 MC2418 A1 MC 2418A1
Authority
MC
Monaco
Prior art keywords
pharmaceutically acceptable
optically active
active compound
esters
methyl
Prior art date
Application number
MC2347A
Other languages
English (en)
French (fr)
Inventor
Stuart Dennett Mills
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/457,538 external-priority patent/US5652242A/en
Priority claimed from GBGB9518188.9A external-priority patent/GB9518188D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of MC2418A1 publication Critical patent/MC2418A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MC2347A 1995-06-01 1996-05-29 Procédé de préparation d'un acide (-) - (3R)-3-méthyl-4-[4-[4- (4-pyridyl) pipérazine-1-yl] phénoxy]butyrique et d'une composition pharmaceutique le contenant MC2418A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/457,538 US5652242A (en) 1993-03-29 1995-06-01 Heterocyclic derivatives
GBGB9518188.9A GB9518188D0 (en) 1995-09-07 1995-09-07 Optically active derivative

Publications (1)

Publication Number Publication Date
MC2418A1 true MC2418A1 (fr) 1997-05-23

Family

ID=26307696

Family Applications (1)

Application Number Title Priority Date Filing Date
MC2347A MC2418A1 (fr) 1995-06-01 1996-05-29 Procédé de préparation d'un acide (-) - (3R)-3-méthyl-4-[4-[4- (4-pyridyl) pipérazine-1-yl] phénoxy]butyrique et d'une composition pharmaceutique le contenant

Country Status (31)

Country Link
EP (1) EP0796247A1 (pt)
JP (1) JP2885941B2 (pt)
KR (1) KR100245957B1 (pt)
AT (1) AT406675B (pt)
AU (1) AU710105B2 (pt)
BE (1) BE1009520A5 (pt)
BR (1) BR9606409A (pt)
CA (1) CA2194397A1 (pt)
CH (1) CH691808A5 (pt)
CZ (1) CZ26997A3 (pt)
DE (1) DE19680509T1 (pt)
DK (1) DK10697A (pt)
ES (1) ES2137886B1 (pt)
FI (1) FI970393A0 (pt)
GB (1) GB2304340B (pt)
GR (1) GR1002702B (pt)
HU (1) HUP9700274A3 (pt)
IE (1) IE960405A1 (pt)
IL (1) IL118477A0 (pt)
IT (1) IT1290839B1 (pt)
LU (1) LU90008B1 (pt)
MC (1) MC2418A1 (pt)
MX (1) MX9700379A (pt)
NL (1) NL1003243C2 (pt)
NO (1) NO307460B1 (pt)
NZ (1) NZ308597A (pt)
PL (1) PL318440A1 (pt)
SE (1) SE510812C2 (pt)
SK (1) SK13097A3 (pt)
TR (1) TR199700020T1 (pt)
WO (1) WO1996038416A1 (pt)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100158A3 (en) * 1982-07-28 1985-03-27 The Upjohn Company (3-pyridinyl)heteroalkarylalkanols, alkanoic acids and esters
GB8609630D0 (en) * 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents
AU692438B2 (en) * 1993-03-29 1998-06-11 Astrazeneca Ab Heterocyclic derivatives as platelet aggregation inhibitors
EP0690847A1 (en) * 1993-03-29 1996-01-10 Zeneca Limited Heterocyclic compounds as platelet aggregation inhibitors

Also Published As

Publication number Publication date
NO970437D0 (no) 1997-01-31
HUP9700274A2 (hu) 1999-06-28
JP2885941B2 (ja) 1999-04-26
FI970393L (fi) 1997-01-30
SE9700203L (sv) 1997-01-24
IL118477A0 (en) 1996-09-12
ITMI961113A0 (it) 1996-05-31
NL1003243C2 (nl) 1996-12-04
NZ308597A (en) 1998-11-25
JPH09512836A (ja) 1997-12-22
AT406675B (de) 2000-07-25
EP0796247A1 (en) 1997-09-24
CH691808A5 (de) 2001-10-31
TR199700020T1 (tr) 1997-04-22
GB2304340A (en) 1997-03-19
GB9627127D0 (en) 1997-02-19
ES2137886B1 (es) 2000-08-16
ES2137886A1 (es) 1999-12-16
HU9700274D0 (en) 1997-04-28
CZ26997A3 (en) 1997-08-13
SE9700203D0 (sv) 1997-01-24
BR9606409A (pt) 1997-09-30
SE510812C2 (sv) 1999-06-28
BE1009520A5 (fr) 1997-04-01
NO307460B1 (no) 2000-04-10
GR1002702B (el) 1997-05-22
MX9700379A (es) 1997-04-30
FI970393A7 (fi) 1997-01-30
IT1290839B1 (it) 1998-12-14
ITMI961113A1 (it) 1997-12-01
AU5827296A (en) 1996-12-18
FI970393A0 (fi) 1997-01-30
LU90008B1 (fr) 1997-04-16
KR100245957B1 (ko) 2000-04-01
IE960405A1 (en) 1996-12-11
ATA900596A (de) 1999-12-15
DK10697A (da) 1997-04-01
GB2304340B (en) 1998-07-29
SK13097A3 (en) 1997-08-06
KR970704689A (ko) 1997-09-06
CA2194397A1 (en) 1996-12-05
DE19680509T1 (de) 1997-12-04
NO970437L (no) 1997-02-20
PL318440A1 (en) 1997-06-09
AU710105B2 (en) 1999-09-16
HUP9700274A3 (en) 2000-02-28
WO1996038416A1 (en) 1996-12-05

Similar Documents

Publication Publication Date Title
TWI729443B (zh) 做為組蛋白去乙醯酶6抑制劑之1,3,4-㗁二唑衍生物及包含彼之醫藥組合物
EP3828173A1 (en) Substituted pyrazoles as human plasma kallikrein inhibitors
EP0629616A2 (fr) Dérivés optiquement actifs de 2-imidazoline-5-ones et 2-imidazoline-5-thiones fongicides
EP1546111A2 (fr) Composes derives de la 2-thiohydantoine et leur utilisation pour le traitement du diabete
FR2515179A1 (fr) Derives de pyrrolidine, leur procede de preparation, les intermediaires pour leur synthese et leur application therapeutique
JP2018526448A (ja) 一酸化窒素を放出可能なプロドラッグ分子
KR100939243B1 (ko) 포타슘 채널의 기능을 조절하는 아민 유도체, 그의제조방법 및 용도
EP0719775B1 (fr) Dérivés de Phényl-4-thiazoles substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant
US8765953B2 (en) Compounds and methods for the treatment of pain and other diseases
MC1706A1 (fr) Dérivés de tétrahydronaphtalène
JPH06192199A (ja) ケトン誘導体
CA2089349C (fr) Nouveaux derives de pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1828125B1 (fr) Derives d'arylpiperazine et leur utilisation comme ligands selectifs du recepteur d3 de la dopamine
FR2602231A1 (fr) Nouveaux derives de la dihydro-1,4 pyridine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
EP2725025A1 (fr) Dérives de 1H-indole-3-carboxamide et leurs utilisation comme antagonistes du P2Y12
BE1009520A5 (fr) Acide (-)-(3r)-3-methyl-4- 4-[4-(4-pyridyl)-piperazin-1-yl] phenoxy butyrique.
FR2641534A1 (fr) Nouveaux derives de glycine utiles comme medicaments antagonistes du thromboxane a2 et procede pour leur preparation
FR2734818A1 (fr) Acide (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazine-1-yl- phenoxy}-butyrique, procede pour sa preparation et composition pharmaceutique le contenant
EP0395526B1 (fr) Nouveaux dérivés benzothiazolinoniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
CA2887420A1 (en) Matrix metalloproteinase inhibitors and methods for the treatment of pain and other diseases
EP1098878A1 (fr) Bispiperidines comme agents antithrombotiques
EP0430800B1 (fr) Nouvelles benzothiazolinones substituées, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
EP0994857A1 (fr) DERIVES DE (1$i(H)-IMIDAZOL-4-YL)PIPERIDINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
RU2365585C2 (ru) Противовоспалительные средства
JPH11171881A (ja) 含酸素複素環誘導体